109 related articles for article (PubMed ID: 20045207)
1. Common polymorphism +45T/G in adiponectin gene as potential modulator of in-stent restenosis development.
Bienertova-Vasku J; Bienert P; Hlinomaz O; Vasku A
Int J Cardiol; 2010 Nov; 145(2):351. PubMed ID: 20045207
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphism of adiponectin in restenosis after coronary stenting.
Li HC; Cao GQ; Liu CZ; Tang MM; Zhang XQ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):287-293. PubMed ID: 31389602
[TBL] [Abstract][Full Text] [Related]
3. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.
Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y
Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635
[TBL] [Abstract][Full Text] [Related]
5. The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study.
Nozari Y; Vosooghi S; Boroumand M; Poorhosseini H; Nematipour E; Salarifar M; Kassaian SE; Amirzadegan A; Alidoosti M; Haji-Zeinali AM; Saroukhani S
Anatol J Cardiol; 2015 May; 15(5):348-53. PubMed ID: 25993709
[TBL] [Abstract][Full Text] [Related]
6. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
Gulesserian T; Wenzel C; Endler G; Sunder-Plassmann R; Marsik C; Mannhalter C; Iordanova N; Gyöngyösi M; Wojta J; Mustafa S; Wagner O; Huber K
Clin Chem; 2005 Sep; 51(9):1661-5. PubMed ID: 16020495
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of interleukin-10 gene polymorphism with restenosis after percutaneous coronary intervention in Chinese].
Gao J; Cui RZ; Liu Y; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM; Liu T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):42-6. PubMed ID: 21287508
[TBL] [Abstract][Full Text] [Related]
8. [Progress in genetic and epigenetic research on in-stent restenosis after percutaneous coronary interventions].
Kang YH; Lao HY; Yu XY; Chen JY; Zhong SL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):38-42. PubMed ID: 22311489
[TBL] [Abstract][Full Text] [Related]
9. Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries.
Kitta Y; Takano H; Nakamura T; Kodama Y; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
Int J Cardiol; 2008 Dec; 131(1):78-82. PubMed ID: 18180052
[TBL] [Abstract][Full Text] [Related]
10. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin gene polymorphisms and the risk of angiographic coronary in-stent restenosis.
Rittersma SZ; Boekholdt SM; Koch KT; Geuzebroek R; Bax M; Schotborgh CE; Eckmann H; Peters RJ; Piek JJ; Tijssen JG; Reitsma PH; de Winter RJ
Am J Med; 2004 Apr; 116(7):499-500. PubMed ID: 15047045
[No Abstract] [Full Text] [Related]
12. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
13. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
[TBL] [Abstract][Full Text] [Related]
14. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
[TBL] [Abstract][Full Text] [Related]
15. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
Nishimura M; Takahashi H
Rinsho Byori; 2011 Aug; 59(8):795-800. PubMed ID: 21942090
[TBL] [Abstract][Full Text] [Related]
16. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.
Wijpkema JS; van Haelst PL; Monraats PS; Bruinenberg M; Zwinderman AH; Zijlstra F; van der Steege G; de Winter RJ; Doevendans PA; Waltenberger J; Jukema JW; Tio RA
Pharmacogenet Genomics; 2006 May; 16(5):331-7. PubMed ID: 16609364
[TBL] [Abstract][Full Text] [Related]
17. The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.
Falcone C; Emanuele E; Buzzi MP; Ballerini L; Repetto A; Canosi U; Mazzucchelli I; Schirinzi S; Sbarsi I; Boiocchi C; Cuccia M
Int J Immunopathol Pharmacol; 2007; 20(4):771-7. PubMed ID: 18179750
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
20. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
